whatshot

ACRV   $1.49  3.47% Market Open

Acrivon Therapeutics, Inc.
show_chart Advanced Chart of ACRV
Last Events:

2023-08-09 Signal in Stochastic changed from bearish recovery to bearish weakening. The stochastic indicator is in the lower part of the neutral territory and it heading north. These factors indicate that the upside trend is forming Last signal: main and signal line crossing.

2023-08-09 Signal in RSI changed from bearish recovery to bearish weakening. RSI indicator is in the lower part of the neutral territory and it heading north. These factors indicate that the upside trend is forming Last signal: exit from the overbought zone.

2023-08-09 Trend Power changed from slow to almost flat.

2023-08-06 Trend pattern changed from нисходящий треугольник to канал.

2023-08-06 Signal in RSI changed from bearish weakening to bearish recovery. RSI indicator is in the lower part of the neutral territory and it heading south. These factors indicate that negative dynamics is recovering. Last signal: exit from the overbought zone.

2023-08-06 Trend Power changed from almost flat to slow.

2023-08-05 Signal in Stochastic changed from bearish to bearish recovery. The stochastic indicator is in the lower part of the neutral territory and it falls. These factors indicate that negative dynamics persists. Last signal: main and signal line crossing.

2023-08-05 Signal in RSI changed from bearish to bearish weakening. RSI indicator is in the lower part of the neutral territory and it heading north. These factors indicate that the upside trend is forming Last signal: exit from the overbought zone.

Current temperature: 0.00
ST: 0, Cor:

Analyst Recommendations:
Number of estimates 6
Target Price Mean 11.50
Mean unverified/preliminary 11.50 / 11.50
Target Price Low / High 7.00 / 19.00
Median / STD DEV 10.50 / 4.68
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total ActivelyBuy Buy Buy
rsi ActivelyBuy Buy ActivelyBuy
macd None ActivelyBuy None
stoch ActivelyBuy None None
ma20 Sell ActivelyBuy None
ma50 ActivelyBuy None None
ma100 ActivelyBuy Buy Buy
Candlestick PatternJune 10, 2026 Doji - is formed when the open and the close are the same or very close. The body of candle is small. The length of the shadows are not important. The appearance of a Doji should alert the investor of major indecision.
ISIN US0048901096
ceo Dr. Peter Blume-Jensen M.D., Ph.D.
Website https://www.acrivon.com
Acrivon Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing oncology medicines for the patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's Acrivon Predictive Precision Proteomics, a precision medicine platform enables the creation of drug specific proprietary OncoSignature companion diagnostics that are used to identify the patients to benefit from its drug candidates. Its lead clinical candidate is ACR-368, a selective small molecule inhibitor targeting CHK1 and CHK2, which is in Phase II clinical trial across various tumor types, including platinum-resistant ovarian, endometrial, and bladder cancer. The company is also developing its preclinical stage pipeline programs targeting critical nodes in the DNA damage response, or DDR, pathways; and ACR-2316, a dual WEE1/PKMYT1 inhibitor. Acrivon Therapeutics, Inc. was incorporated in 2018 and is based in Watertown, Massachusetts.